ライフサイエンスコーパス: new device

1 medium term, the safety and efficacy of the new device.

2 proof of concept of the capabilities of the new device.

3 derived from the blood samples taken by the new device.

4 ous types of waveforms are possible with the new device.

5 We aimed to test this new device.

6 ived Gianturco-Roubin stents as an unplanned new device.

7 tral regurgitation) is key to the success of new devices.

8 tional patient populations and the design of new devices.

9 nd metal cations are highly sought after for new devices.

10 applications in spintronics, and may lead to new devices.

11 alth consequences or death-as predicates for new devices.

12 s and to mitigate barriers to development of new devices.

13 hem (57.7%) were ultimately reimplanted with new devices.

14 significant potential for the development of new devices.

15 hospitalizations (0.8%) included two or more new devices.

16 ilable with regard to the longevity of these new devices.

17 oducts while expediting access to beneficial new devices.

18 and extends its feasibility for varieties of new devices.

19 ational registries, and evolution of several new devices.

20 ker generators is not inferior to the use of new devices.

21 and anterior chamber depth measurements of 2 new devices, 1 using Scheimpflug technology combined wit

22 tions were eight-fold more likely to involve new device acquisition (6.4% vs 0.8%; p < 0.001).

23 We sought to determine the rate of new device acquisition (specifically, tracheostomy place

24 ntextualization, we compare this to rates of new device acquisition among three comparison cohorts: 1

25 New device acquisition was also higher in severe sepsis

26 children surviving severe sepsis experienced new device acquisition.

27 Data drift caused due to network changes, new device additions, or model degradation alters the pa

28 Also, such a new device allowed real-time measurement and recording o

29 ransformations performed side by side in the new device and a standard microwave reactor suggest that

30 luded if they described the development of a new device and a surgical application was described.

31 We created the new device and assessed it with in-vitro laboratory test

32 tallic surface doping of perovskites enables new device and material designs that combine the intrins

33 chip RNA extraction from infected cells, the new device and protocol can detect Ebola virus in raw bl

34 ctures is of utmost importance in developing new devices and applications of these materials.

35 the comparative effectiveness evaluation of new devices and approaches to treat MR.

36 y has since changed with the availability of new devices and drugs.

37 New devices and improvements in existing devices have re

38 ay function as conductive inorganic nodes in new devices and materials.

39 Introduction of new devices and new techniques are increasing, as eviden

40 3x3 cm2) have all led to the development of new devices and optical probes to monitor physiological

41 y and the safety associated with introducing new devices and procedures into practice.

42 evolution of techniques, the introduction of new devices and the growing experience of operators have

43 e particular advantages in the evaluation of new devices and transcatheter interventions in chronic h

44 te variables (other than charge or voltage), new devices, and new architectures that offer memory and

45 normal) and late mortality after balloon and new device angioplasty has been reported previously.

46 al physical properties - and in turn promise new device applications - as a result of the coupling be

47 Our results point to new device applications such as magnetically recorded fe

48 usual electromagnetic properties and promise new device applications.

49 Our results set a target for the design of new devices approaching the ultimate efficiency limit, a

50 A new device architecture for fast organic transistor memo

51 Here we present a new device architecture for two-dimensional semiconducto

52 y of advanced electrode active materials and new device architectures have been developed.

53 vironments exhibits an important step toward new device architectures with potential relevance to bio

54 lucidating the device mechanisms, developing new device architectures, and improving large-scale manu

55 This imprinting strategy provides access to new device architectures, as demonstrated through the fa

56 portance due to their potential for enabling new device architectures.

57 New devices are becoming available which make the monito

58 New devices are currently engineered to prevent stone mi

59 from the amorphous character of a-ZITO, the new devices are highly flexible and can be repeatedly be

60 These new devices are introducing Raman spectroscopy to a dive

61 It is not clear whether new devices are more effective in this anatomic setting.

62 anic ions level could be evidenced with this new device, assisting the early diagnosis and prevention

63 calibration in longitudinal studies where a new device at follow-up might be error-prone compared to

64 hly sensitive point-of-care troponin assays; new devices available before first medical contact that

65 view was to highlight new techniques and the new devices available to the pediatric interventional ca

66 We describe a new device based on gold-microtube membranes that can ac

67 The development of a new device based on the use of UV-vis bare optical fiber

68 Updates in the new Device-Based Therapy Guidelines for the implantation

69 There are new devices being examined in clinical trials, including

70 This new device can be ideal for preseparation and preconcent

71 We conclude that this new device can be used successfully for testing new agen

72 This enhanced performance enables new device capabilities such as multi-bit storage, thus

73 quality ferroelectric films now be grown for new device capabilities, but ferroelectrics can be combi

74 This new device concept is scalable and easily deployed for a

75 vistic single-particle physics and provide a new device concept toward next-generation quantum device

76 rcumvent this limitation, here we describe a new device concept, based on the application of quasi-co

77 r across the interface as the foundation for new device concepts and applications.

78 solid-state organic lasers are reviewed, and new device concepts and emerging applications are summar

79 emiconductor technology is paving the way to new device concepts for various applications, from quant

80 novel electronic and optical properties, and new device concepts not observed in bulk material system

81 ric films, and has led to the development of new device concepts such as resistive random-access memo

82 imensional materials has emerged in light of new device concepts taking advantage of flexing, adhesio

83 t has been devoted to find new materials and new device concepts that could ultimately outperform sta

84 ns in single-molecule circuits are heralding new device concepts with no classical analogues.

85 diode effect, which builds a foundation for new device concepts.

86 uit fabrication and create possibilities for new device concepts.

87 ot only lead to more stable devices but also new device concepts.

88 To combat this problem, we have developed a new device configuration, the double-gate light-emitting

89 The new device coupled with a portable electrochemical analy

90 We evaluated a new device designed to clean the endotracheal tube in me

91 vely slow and often limits the rate at which new device designs can be built and tested.

92 patients prescribed OAC within 90 days after new device-detected AF across a range of AF thresholds (

93 escription practice variation in response to new device-detected AF and the association with outcomes

94 ice variation in 90-day OAC initiation after new device-detected AF, with low rates of treatment over

95 This new device enhances negative intrathoracic pressure duri

96 year, participants were randomly allocated a new device (EpiPen, Anapen, new EpiPen, JEXT or Auvi-Q),

97 d with a high procedural success rate in the new device era, they have an increased rate of major eve

98 atment of left main coronary stenoses in the new device era.

99 Recent advancement shows that a new device, 'flow-diverter', can divert blood flow away

100 ictive nature, which allows an approach of a new device for electrochemical sensing and biosensing.

101 We also introduced a new device for measuring in vivo fluorescence over time,

102 A new device for parallel-electromembrane extraction (Pa-E

103 We describe a new device for separation of complex biological particle

104 A new device for the assessment of dynamic torsion during

105 Here, we present a new device for the real-time monitoring of oxidative str

106 ential for application in the development of new devices for biosensing.

107 Despite the advent of many new devices for glaucoma surgery, scarring is the main c

108 ass pumps, specifically the TandemHeart; and new devices for institution of extracorporeal membrane o

109 as a theoretical framework for the design of new devices for more efficient water filtration and osmo

110 New devices for performing coronary interventions have b

111 Steps have even been taken to create new devices for the treatment of patients with central v

112 growth of such lateral junctions will allow new device functionalities, such as in-plane transistors

113 semiconductors is a promising route towards new device functionality and performance.

114 Alternatives that are being pursued include new device geometries such as ultrathin channel structur

115 device available to clinicians, a number of new devices have become commercially available and have

116 Finally, three new devices have been developed to manipulate Leidenfros

117 Although many new devices have led to considerable patient benefit, su

118 New devices have recently been approved for use in adole

119 %) with reused devices and in 38 (1.2%) with new devices (hazard ratio, 1.66; 95% confidence interval

120 m the experimental data, indicating that the new devices hold promise for biomedical studies.

121 ith structurally normal hearts who underwent new device implantation at Texas Children's Hospital bet

122 1:3 ratio with control patients who received new devices implanted in Canada.

123 A new device improves the way scientists can record the ac

124 ts receiving the Gianturco-Roubin stent as a new device in an unplanned fashion are included.

125 ution, and sensitivity make it a competitive new device in the class of PET scanners with an extended

126 Gianturco-Roubin flex stents as an unplanned new device in the initial treatment of 350 patients (389

127 hat seen among matched control patients with new devices in Canada.

128 were no arm fractures with either the old or new devices in these dogs.

129 Highlights of these new devices include precisely adjustable absorption edge

130 ith controlled bypass limb length using four new devices including a dedicated lumen-apposing metal s

131 magnetic rotations that might be applied in new devices including microwave sources and resonators.

132 embranes are expected to enable a variety of new devices, including membrane-based chromatography sys

133 against the benefits of rapid translation of new devices into clinical practice.

134 Re-implantation of new devices into the same location demonstrated retinal

135 The new device is highly flexible concerning the used separa

136 attractive performance and advantages of the new device is indicated from comparison to a conventiona

137 The new device is simple and is fast and accurate in measuri

138 which there are many), rather than creating new devices, is a desirable trend that may contribute to

139 Using the new device it was possible to characterize the potency o

140 us TAVR devices and the rapid development of new device iterations, there is insufficient evidence to

141 alls, as well as outcomes' improvements with new device iterations.

142 atrial thrombosis, device dislodgement, or a new device leak were observed.

143 This kind of new device may not only helpful to implement adaptive in

144 New devices may allow patients to complete visual field

145 Whether the use of new devices may attenuate the elevated risk of CABG in p

146 e innovations and technologies emerge, these new devices may become a cornerstone of the management s

147 ermal efficiency between the traditional and new device measured in the laboratory.

148 Most new device models are deemed safe and effective without

149 rd cardiopulmonary resuscitation, use of the new device more than doubled short-term survival rates i

150 The new device, named "worm hospital" allows us to perform t

151 ess communications to become a reality, many new devices need to be developed, such as those for rout

152 New devices, new thrombolytic agents, and new antithromb

153 This new device offers a facile screening approach to determi

154 dictates the utility of FRET and can unlock new device operation motifs including quantum-funnel sol

155 perspectives on routes to commercialization, new device opportunities, and remaining challenges for r

156 ble metallic helical stent was explored as a new device opportunity (magnesium scaffold), which can b

157 laucoma practice patterns change each time a new device or procedure is introduced.

158 of available airway devices, development of new devices, or both may help to promote this goal.

159 These new materials and new devices pave the way for a new generation of electro

160 t is used in the clinical laboratories, this new device performed well in regards to the analytical p

161 crystal tunability in low-n LDPs and unlocks new device possibilities for smart solar facades and ind

162 such as high-frequency diodes or completely new device principles for organics, e.g., bipolar transi

163 25 fmol of [Glu1]-fibrinopeptide B using the new device produced a CE-ESI-MS electropherogram with a

164 trial), and 1 placebo-controlled trial of a new device (Prosorba).

165 As technology continues to improve and new devices provide greater safety and durability, conti

166 tic waves and are an enabling technology for new devices ranging from flat lenses that focus light be

167 For new devices requiring intraoperative trial, the time bet

168 A new device, resuscitative endovascular balloon occlusion

169 ozyme device platform to efficiently isolate new device sequences that exhibit increased in vitro cle

170 The availability of this new device should make this measurement technology acces

171 Whilst some of these new devices show promise in the outpatient setting, furt

172 Finally, we propose a new, device-specific islet equivalence conversion table,

173 Beyond this timeframe, entirely new device structures (such as nanowire or molecular dev

174 content and high geometric freedom, enabling new device structures and applications.

175 dielectrics and metal gate electrodes), and new device structures are required.

176 en the cornerstone of medical communication, new devices such as cellular telephones, personal digita

177 Studies of new devices such as laryngoscopes and the use of the lar

178 Such action will ensure timely access to the new device technologies that are necessary for the growt

179 New device technologies, such as intracoronary stenting;

180 New device technology developed in the clinical research

181 A new device technology is also presented that uses a meta

182 be accomplished safely and effectively with new device technology.

183 The new device, termed a periodic focusing ion funnel (PF IF

184 In this study, we present a new device that allows for high-resolution imaging of th

185 This study evaluates a new device that has been proposed to continuously monito

186 erative that close scrutiny be given to each new device that hits the market to ensure they perform o

187 stacking order in graphene opens the way to new devices that combine structural and electrical prope

188 rly review available devices and investigate new devices that emerge each year.

189 tatements for competency, new techniques and new devices that have been developed, and perhaps most i

190 To overcome this constraint, we developed new devices that integrate ultrathin and flexible silico

191 r is not gone: there are billions of old and new devices that need to transition to the PQC suite of

192 considerations for evidence development for new devices that will define which patients with PE woul

193 This new device thus has the potential for rapid analysis of

194 The iStent inject is a promising new device to lower intraocular pressure via TM bypass.

195 A new device to perform spectroelectrochemical measurement

196 e inadequate, and there is a need to develop new devices to empower movements and facilitate physical

197 s upgrades of the neutron facilities require new devices to perform experiments with maximum performa

198 ent of acute ischemic stroke mainly focus on new devices to reperfuse ischemic brain.

199 The new device uses dialysis membranes (DMs) paired with ion

200 A new device utilizing electrical nano pulsing (ENP) has b

201 for all condom failure events for the three new devices versus the FC2, within the predefined margin

202 With the development of new devices, vision screening can effectively be perform

203 During the index hospitalization, a new device was implanted in 54 patients at a median of 7

204 The analytical performance of these new devices was demonstrated using water samples spiked

205 The new device will enable high-throughput studies of quanta

206 aimed to compare thermal ablation using the new device with cryotherapy.

207 er variability of 0.77 mm and generalised to new devices with 0.63 mm, 0.67 mm and 0.87 mm (p < 0.001

208 New devices with 22 um pixels increased the grating acui

209 ld confirmed the safety and efficacy of this new device, with vasomotion restoration and continued de

210 When switched to a new device without specific training, success rates were